Scopus BioPharma, Inc.

Scopus BioPharma, Inc. financial statements

Scopus BioPharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2022

RevenueUSD 0EODHD
Net income−USD 11.61MEODHD
Cash and equivalentsUSD 124.58KEODHD

Scopus BioPharma, Inc. financials on 6ix · Scopus BioPharma, Inc. on 6ix